Immediate Impact
35 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Eric Bernstein being referenced
A Randomized, Placebo-Controlled, Multicenter, Biomarker-Selected, Phase 2 Study of Apricoxib in Combination with Erlotinib in Patients with Advanced Non–Small-Cell Lung Cancer
2014
Evaluation of nuclear factor κB and chemokine receptor CXCR4 co‐expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eric Bernstein | 36 | 30 | 17 | 23 | 8 | 81 | |
| Andrea Lindgren | 29 | 41 | 15 | 41 | 11 | 164 | |
| Roya Behrouzi | 16 | 29 | 4 | 43 | 10 | 167 | |
| Adem Albayrak | 31 | 62 | 4 | 43 | 7 | 119 | |
| P. Hill | 12 | 45 | 4 | 42 | 7 | 102 | |
| S. Lindsey Davis | 15 | 45 | 5 | 40 | 7 | 92 | |
| Clive Hayward | 38 | 24 | 12 | 23 | 6 | 175 | |
| Isabel Mayayo‐Peralta | 66 | 73 | 7 | 65 | 11 | 171 | |
| Dana J. Fraser | 25 | 30 | 19 | 51 | 8 | 186 | |
| Jean-Michel Rodier | 35 | 37 | 2 | 25 | 8 | 90 | |
| Fabio Volterra | 29 | 48 | 7 | 52 | 8 | 107 |
All Works
Loading papers...